|
US3891427A
(en)
*
|
1972-10-12 |
1975-06-24 |
Lectromelt Corp |
Method for melting prereduced ore and scrap
|
|
SE378735B
(enExample)
*
|
1972-11-17 |
1975-09-08 |
Asea Ab |
|
|
US3939297A
(en)
*
|
1973-12-07 |
1976-02-17 |
Chase Brass & Copper Co., Incorporated |
Stoker feed system
|
|
SE7503782L
(sv)
*
|
1975-04-02 |
1976-10-03 |
Asea Ab |
Sett och anordning for smeltreduktion av finkornigt jernoxidhaltigt material
|
|
DE2632707C3
(de)
*
|
1976-07-21 |
1983-04-07 |
Ernst Dipl.-Ing. 4006 Erkrath Beiersdorf |
Beschickungsanlage an Elektro-Lichtbogenöfen zur Zugabe von Legierungsmitteln und Zuschlagstoffen
|
|
US4133967A
(en)
*
|
1977-06-24 |
1979-01-09 |
The United States Of America As Represented By The Secretary Of The Interior |
Two-stage electric arc - electroslag process and apparatus for continuous steelmaking
|
|
US4447906A
(en)
*
|
1981-02-02 |
1984-05-08 |
Lectromelt Corporation |
Arc furnace for producing aluminum
|
|
SE8303372L
(sv)
*
|
1983-06-14 |
1984-12-15 |
Asea Ab |
Ugnsanordning for smeltning av metaller eller metallegeringar
|
|
AT384669B
(de)
*
|
1986-03-17 |
1987-12-28 |
Voest Alpine Ag |
Anlage zur herstellung von stahl aus schrott
|
|
CA1311787C
(en)
*
|
1986-06-24 |
1992-12-22 |
Masahisa Tate |
Method of bottom blowing operation of a steel making electric furnace
|
|
FR2705767B1
(fr)
*
|
1993-05-27 |
1995-07-21 |
Lorraine Laminage |
Procédé et installation de production d'acier liquide à partir de matières ferreuses riches en matières carbonées.
|
|
DE4339226A1
(de)
*
|
1993-11-15 |
1995-05-18 |
Mannesmann Ag |
Verfahren und Vorrichtung zur Wertstoffgewinnung
|
|
LU88517A7
(fr)
*
|
1993-12-15 |
1996-02-01 |
Wurth Paul Sa |
Dispositif de chargement d'un four électrique
|
|
AT404841B
(de)
*
|
1995-04-10 |
1999-03-25 |
Voest Alpine Ind Anlagen |
Anlage und verfahren zum herstellen von eisenschmelzen
|
|
US6673827B1
(en)
|
1999-06-29 |
2004-01-06 |
The Uab Research Foundation |
Methods of treating fungal infections with inhibitors of NAD synthetase enzyme
|
|
US7227011B2
(en)
|
1998-06-04 |
2007-06-05 |
United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Nucleic acid vaccines for prevention of flavivirus infection
|
|
AU5273700A
(en)
*
|
1999-05-18 |
2000-12-05 |
Danieli Technology, Inc. |
Electric arc furnace for continuous charging
|
|
EP1702983A3
(en)
|
2000-04-13 |
2007-01-10 |
Medical University of South Carolina |
Tissue-specific and pathogen-specific toxic agents, ribozymes, DNAzymes and antisense oligonucleotides and methods of use thereof
|
|
AU7887501A
(en)
*
|
2000-07-06 |
2002-01-21 |
Us Gov Health & Human Serv |
Tetrahydrobenzothiazole analogues as neuroprotective agents
|
|
AU2001276957A1
(en)
*
|
2000-07-17 |
2002-01-30 |
Advanced Research And Technology Institute |
Method of diagnosing pulmonary hypertension
|
|
EP2336166A1
(en)
|
2000-10-12 |
2011-06-22 |
University Of Rochester |
Compositions that inhibit proliferation of cancer cells
|
|
US20040245317A1
(en)
*
|
2001-04-06 |
2004-12-09 |
Vladimir Larionov |
Artificial chromosomes that can shuttle between bacteria yeast and mammalian cells
|
|
KR20040045041A
(ko)
*
|
2001-10-01 |
2004-05-31 |
반더빌트유니버시티 |
구조적 심장 질환에서의 심근 기능장애를 치료하기 위한칼모듈린 키나제 ⅱ 억제제의 용도
|
|
AU2002332027A1
(en)
*
|
2001-10-04 |
2003-04-14 |
The Government Of The United States Of America, As |
Tandem repeat markers
|
|
DE60332756D1
(de)
|
2002-02-06 |
2010-07-08 |
Vicor Technologies Inc |
Anti-infarkt-moleküle
|
|
US7666411B2
(en)
|
2002-06-14 |
2010-02-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Methods of treating and preventing colitis involving IL-13 and NK-T cells
|
|
WO2004013160A2
(en)
|
2002-08-05 |
2004-02-12 |
University Of Rochester |
Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
|
|
CA2505601C
(en)
|
2002-11-15 |
2014-10-28 |
Musc Foundation For Research Development |
Complement receptor 2 targeted complement modulators
|
|
ATE542423T1
(de)
|
2002-11-21 |
2012-02-15 |
Univ Utah Res Found |
Purinerge geruchsmodulation
|
|
CA2553745A1
(en)
|
2004-01-21 |
2005-08-04 |
University Of Utah Research Foundation |
Mutant sodium channel nav1.7 and methods related thereto
|
|
AU2005220874B2
(en)
|
2004-03-04 |
2010-12-23 |
Vanderbilt University |
Cell-penetrating SOCS polypeptides that inhibit cytokine-induced signaling
|
|
WO2006016904A2
(en)
*
|
2004-04-14 |
2006-02-16 |
Uab Research Foundation |
Activators of hexosamine biosynthesis as inhibitors of injury induced by ischemia or hemorrhagic shock
|
|
US20050244335A1
(en)
*
|
2004-05-03 |
2005-11-03 |
Rinehart John J |
Methods and compositions related to increasing antitumor activity of chemotherapeutic agents
|
|
CA2566703A1
(en)
|
2004-05-11 |
2005-11-24 |
Vishwa Deep Dixit |
Methods of inhibiting proinflammatory cytokine expression using ghrelin
|
|
US8039588B2
(en)
|
2004-05-21 |
2011-10-18 |
The Uab Research Foundation |
Variable lymphocyte receptors
|
|
WO2006055875A2
(en)
*
|
2004-11-18 |
2006-05-26 |
University Of Rochester |
Methods and compositions related to esculentoside a
|
|
DK2377546T3
(en)
|
2004-12-21 |
2017-02-13 |
Musc Found For Res Dev |
Compositions and Methods to Promote Wound Healing and Tissue Regeneration
|
|
WO2006113614A2
(en)
|
2005-04-15 |
2006-10-26 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Service National Institutes Of Health |
Methods of treating and preventing inflammatory bowel disease involving il-13 and nkt cells
|
|
EP1931700B1
(en)
|
2005-05-19 |
2013-07-17 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES |
FUNCTIONAL EPITOPES OF STREPTOCOCCUS PNEUMONIAE PsaA ANTIGEN AND USES THEREOF
|
|
US8859585B2
(en)
*
|
2005-05-25 |
2014-10-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Scopolamine for the treatment of depression and anxiety
|
|
ES2626018T3
(es)
|
2005-06-07 |
2017-07-21 |
Dsm Nutritional Products Ag |
Microorganismos eucariotas para la producción de lípidos y antioxidantes
|
|
EP2395076A1
(en)
|
2005-10-14 |
2011-12-14 |
MUSC Foundation For Research Development |
Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy
|
|
US8080534B2
(en)
|
2005-10-14 |
2011-12-20 |
Phigenix, Inc |
Targeting PAX2 for the treatment of breast cancer
|
|
EP2653542B1
(en)
|
2005-12-29 |
2016-06-29 |
The Regents of The University of California |
Methods and compositions related to mutant kunitz domain I of TFPI-2
|
|
WO2007081792A2
(en)
|
2006-01-05 |
2007-07-19 |
University Of Utah Research Foundation |
Methods and compositions related to improving properties of pharmacological agents targeting nervous system
|
|
EP2510943B1
(en)
|
2006-02-06 |
2016-04-20 |
The Burnham Institute for Medical Research |
Methods and compositions related to targeting tumors and wounds
|
|
US8470965B2
(en)
*
|
2006-03-01 |
2013-06-25 |
University Of Utah Research Foundation |
Methods and compositions related to cyclic peptide synthesis
|
|
AU2007223427A1
(en)
*
|
2006-03-01 |
2007-09-13 |
University Of Utah Research Foundation |
Methods and compositions related to cyclic peptide synthesis
|
|
WO2007101274A2
(en)
|
2006-03-02 |
2007-09-07 |
The Uab Research Foundation |
Mycobacterial disease detection, treatment, and drug discovery
|
|
EP2043642B1
(en)
|
2006-07-10 |
2015-03-25 |
Synapsin Pharmaceuticals, Inc. |
Compositions and methods relating to solenopsins and their uses in treating neurological disorders and enhancing physical performance
|
|
EP2049564B1
(en)
|
2006-08-02 |
2017-05-17 |
The UAB Research Foundation |
Methods and compositions related to soluble monoclonal variable lymphocyte receptors of defined antigen specificity
|
|
AU2007297535C1
(en)
|
2006-09-21 |
2017-11-23 |
University Of Florida Research Foundation, Inc. |
Compositions and methods related to protein displacement therapy for myotonic distrophy
|
|
WO2008136852A2
(en)
|
2006-11-01 |
2008-11-13 |
University Of Rochester |
Methods and compositions related to the structure and function of apobec3g
|
|
WO2008073441A2
(en)
|
2006-12-11 |
2008-06-19 |
University Of Utah Research Foundation |
Compositions and methods for treating pathologic angiogenesis and vascular permeability
|
|
US20120030779A1
(en)
|
2007-01-18 |
2012-02-02 |
University Of Utah Research Foundtion |
Compositions and methods for detecting, treating, or preventing reductive stress
|
|
EP2596799B1
(en)
|
2007-02-08 |
2016-11-23 |
University of Utah Research Foundation |
Methods and compositions related to inhibition of viral entry
|
|
EP2139319A4
(en)
|
2007-03-22 |
2011-02-23 |
Univ Yale |
METHOD AND COMPOSITIONS FOR RIBOSWITCHES CONTROLLING THE ALTERNATIVE SPLICE
|
|
US8119693B2
(en)
|
2007-05-08 |
2012-02-21 |
Sanford-Burnham Medical Research Institute |
Tissue non-specific alkaline phosphatase inhibitors and uses thereof for treating vascular calcification
|
|
EP2155894A4
(en)
|
2007-05-09 |
2010-08-18 |
Burnham Inst Medical Research |
HOST PROTEINAS AS A TARGET FOR A THERAPEUTIC STRATEGY AGAINST VIRAL AND BACTERIAL DISEASES
|
|
US8329195B2
(en)
|
2007-05-23 |
2012-12-11 |
The Uab Research Foundation |
Detoxified pneumococcal neuraminidase and uses thereof
|
|
SG174103A1
(en)
|
2007-05-29 |
2011-09-29 |
Univ Yale |
Riboswitches and methods and compositions for use of and with riboswitches
|
|
DK2166845T3
(en)
|
2007-06-21 |
2016-02-01 |
Musc Found For Res Dev |
ALFA-connexin C-terminal (ACT) peptides FOR THE TREATMENT OF AGE-related macular degeneration
|
|
TW200916113A
(en)
|
2007-08-08 |
2009-04-16 |
Sod Conseils Rech Applic |
Method for inhibiting inflammation and pro-inflammatory cytokine/chemokine expression using a ghrelin analogue
|
|
WO2009021163A2
(en)
*
|
2007-08-08 |
2009-02-12 |
University Of Rochester |
Enhancing gene transfer
|
|
EP2190466A4
(en)
*
|
2007-08-10 |
2011-12-21 |
Burnham Inst Medical Research |
Tissue-specific alkaline phosphatase (TNAP) activators and their use
|
|
EP2268664B1
(en)
|
2007-12-03 |
2017-05-24 |
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services |
Doc1 compositions and methods for treating cancer
|
|
US20090233993A1
(en)
*
|
2008-03-06 |
2009-09-17 |
Burnham Institute For Medical Research |
Compositions and methods for inhibiting gsk3 activity and uses thereof
|
|
EP2853897A1
(en)
|
2008-05-08 |
2015-04-01 |
University Of Utah Research Foundation |
Sensory receptors for chronic fatigue and pain and uses thereof
|
|
US20090291073A1
(en)
*
|
2008-05-20 |
2009-11-26 |
Ward Keith W |
Compositions Comprising PKC-theta and Methods for Treating or Controlling Ophthalmic Disorders Using Same
|
|
WO2010019963A2
(en)
*
|
2008-08-15 |
2010-02-18 |
Georgetown University |
Na channels, disease, and related assays and compositions
|
|
WO2010065617A1
(en)
|
2008-12-02 |
2010-06-10 |
University Of Utah Research Foundation |
Pde1 as a target therapeutic in heart disease
|
|
US20100286762A1
(en)
*
|
2009-03-18 |
2010-11-11 |
Musc Foundation For Research Development |
Compositions and Methods for Ameliorating Clinical Electrical Disturbances
|
|
US20120107331A1
(en)
|
2009-05-15 |
2012-05-03 |
Yale University |
Gemm riboswitches, structure-based compound design with gemm riboswitches, and methods and compositions for use of and with gemm riboswitches
|
|
WO2011020107A2
(en)
|
2009-08-14 |
2011-02-17 |
Georgetown University |
Compositions and methods for detection and treatment of breast cancer
|
|
US20120149663A1
(en)
|
2009-08-18 |
2012-06-14 |
Georgetown University |
Boronic acid compositions and methods related to cancer
|
|
US20110060000A1
(en)
|
2009-09-10 |
2011-03-10 |
Maurizio Grimaldi |
Acridine analogs in the treatment of gliomas
|
|
SG182365A1
(en)
|
2010-01-12 |
2012-08-30 |
Univ Yale |
Structured rna motifs and compounds and methods for their use
|
|
WO2011112670A2
(en)
|
2010-03-09 |
2011-09-15 |
Board Of Regents, University Of Texas System |
Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease
|
|
JP2013525285A
(ja)
|
2010-04-08 |
2013-06-20 |
サンフォード−バーナム メディカル リサーチ インスティテュート |
化合物の送達を増強するための方法および組成物
|
|
US20130143955A1
(en)
|
2010-08-09 |
2013-06-06 |
Yale University |
Cyclic di-GMP-II Riboswitches, Motifs, and Compounds, and Methods for Their Use
|
|
WO2012082942A2
(en)
|
2010-12-15 |
2012-06-21 |
Neuroadjuvants, Inc. |
Neuropeptide analogs, compositions, and methods for treating pain
|
|
SG193500A1
(en)
|
2011-03-15 |
2013-10-30 |
Univ Utah Res Found |
Methods of diagnosing and treating vascular associated maculopathy and symptoms thereof
|
|
JP6205345B2
(ja)
|
2011-03-28 |
2017-09-27 |
ユニヴァーシティー オブ ユタ リサーチ ファウンデーション |
ウイルス侵入の阻害に関する方法および組成物
|
|
WO2013036636A1
(en)
|
2011-09-06 |
2013-03-14 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods of treating cancer
|
|
EP2870238A4
(en)
|
2012-07-05 |
2016-03-09 |
Ohio State Innovation Foundation |
COMPOSITIONS AND METHODS RELATED TO VIRAL VACCINES
|
|
WO2014141111A1
(en)
|
2013-03-14 |
2014-09-18 |
Pluristem Ltd. |
Methods for prevention and treatment of graft-versus-host disease
|
|
WO2014201118A2
(en)
|
2013-06-11 |
2014-12-18 |
Sanford-Burnham Medical Research Institute |
Compositions and methods for targeted endometriosis treatment
|
|
RS59925B1
(sr)
|
2013-07-05 |
2020-03-31 |
H Lee Moffitt Cancer Center And Research Institute Inc |
Rastvorljivi cd33 za lečenje mijelodisplastičnih sindroma (mds)
|
|
US9884895B2
(en)
|
2014-03-20 |
2018-02-06 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for chimeric coronavirus spike proteins
|
|
WO2016049380A1
(en)
|
2014-09-24 |
2016-03-31 |
University Of Utah Research Foundation |
Ebolavirus pre-hairpin intermediate mimics and methods of use
|
|
JP2018504141A
(ja)
|
2015-01-20 |
2018-02-15 |
アドキュア バイオテクノロジーズ、 エルエルシー |
非標的化アデノウイルス変異体および関連する方法
|
|
HK1248554A1
(zh)
|
2015-02-20 |
2018-10-19 |
Board Of Regents, The University Of Texas System |
作为疫苗和载体的减毒衣原体的方法和组合物
|
|
WO2017040350A1
(en)
|
2015-08-28 |
2017-03-09 |
Navigen, Inc |
Compositions and methods related to inhibition of respiratory syncytial virus entry
|
|
WO2017120549A1
(en)
|
2016-01-07 |
2017-07-13 |
Navigen, Inc. |
D-peptide inhibitors of hiv entry and methods of use
|
|
KR102477922B1
(ko)
|
2016-03-16 |
2022-12-14 |
아베오미 코포레이션 |
Il-25에 대한 중화 모노클로날 항체 및 그의 용도
|
|
US10751340B2
(en)
|
2016-06-06 |
2020-08-25 |
University Of Central Florida Research Foundation, Inc. |
Combination therapy to improve brain function or promote neurogenesis for treating neurodegenerative conditions
|
|
BR112019001737A2
(pt)
|
2016-07-29 |
2019-05-07 |
Ohio State Innovation Foundation |
expressão de pten-long com vírus oncolíticos
|
|
CN118453850A
(zh)
|
2016-10-05 |
2024-08-09 |
弗罗里达中央大学研究基金会 |
涉及nk细胞和抗pdl1癌症治疗的方法和组合物
|
|
KR102811217B1
(ko)
|
2017-02-28 |
2025-05-22 |
유니버시티 오브 센트럴 플로리다 리서치 파운데이션, 인코포레이티드 |
Nk 세포의 골수 호밍을 개선시키는 pm21 입자
|
|
WO2018176027A1
(en)
|
2017-03-24 |
2018-09-27 |
Ohio State Innovation Foundation |
Novel recombinant adeno-associated viral vectors restricting off-target transduction in liver and uses thereof
|
|
AU2018243920B2
(en)
|
2017-03-28 |
2024-12-12 |
Mayo Foundation For Medical Education And Research |
Human PD1 peptide vaccines and uses thereof
|
|
EP3615052B1
(en)
|
2017-04-27 |
2023-01-25 |
The University of Hong Kong |
Use of hcn inhibitors for treatment of cancer
|
|
KR20240132124A
(ko)
|
2017-05-25 |
2024-09-02 |
유니버시티 오브 센트럴 플로리다 리서치 파운데이션, 인코포레이티드 |
천연 살해 세포에 의해 사멸하는 종양 세포를 감작시키기 위한 신규한 종양용해 바이러스
|
|
WO2019067403A2
(en)
|
2017-09-26 |
2019-04-04 |
Sanford Burnham Prebys Medical Discovery Institute |
COMPOSITIONS AND METHODS FOR EVALUATION OF PAINFUL DEMYELINIZING AND NON-DEMYELING DISEASES
|
|
US12053523B2
(en)
|
2017-12-13 |
2024-08-06 |
North Carolina State University |
Compositions comprising chemotherapeutic agents and checkpoint inhibitors and methods of use
|
|
WO2019195819A1
(en)
|
2018-04-06 |
2019-10-10 |
North Carolina State University |
Cell assembly-mediated delivery of checkpoint inhibitors for cancer immunotherapy
|
|
US11717551B2
(en)
|
2018-05-07 |
2023-08-08 |
Georgia State University Research Foundation, Inc. |
Compositions and methods related to Rhamnus prinoides (GESHO) extract for the inhibition of polymicrobial biofilm formation
|
|
KR102846479B1
(ko)
|
2018-05-16 |
2025-08-18 |
더 리서치 인스티튜트 앳 네이션와이드 칠드런스 하스피탈 |
Cas9 리보핵단백질을 사용하는 녹아웃 일차 및 확장된 인간 nk 세포의 생성
|
|
KR20210042268A
(ko)
|
2018-05-30 |
2021-04-19 |
다이렉트 바이오로직스 엘엘씨 |
간엽 줄기 세포(msc) 제제를 포함하는 성장 인자 및 세포외 소포 냉동 또는 분말화 첨가제 및 사용 방법
|
|
US20210260187A1
(en)
|
2018-06-29 |
2021-08-26 |
North Carolina State University |
In situ sprayed bioresponsive immunotherapeutic gel for post-surgical treatment
|
|
US11331269B2
(en)
|
2018-09-06 |
2022-05-17 |
Massachusetts Institute Of Technology |
Methods and compositions targeting lung microbiota and its responding immune pathways for lung cancer treatment
|
|
US20210317479A1
(en)
|
2018-09-06 |
2021-10-14 |
The Broad Institute, Inc. |
Nucleic acid assemblies for use in targeted delivery
|
|
WO2020072764A1
(en)
|
2018-10-03 |
2020-04-09 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Covalent adaptor synnotch and chimeric antigen receptors (cars) for programmable antigen-targeting
|
|
US20210388389A1
(en)
|
2018-10-30 |
2021-12-16 |
Yale University |
Compositions and methods for rapid and modular generation of chimeric antigen receptor t cells
|
|
EP3873505A4
(en)
|
2018-11-02 |
2022-08-10 |
The Johns Hopkins University |
ADENOVIRAL CHIMERA TDP-43 PROTEINS
|
|
US20220136064A1
(en)
|
2019-02-09 |
2022-05-05 |
King Abdullah University Of Science And Technology |
Compositions and methods for cancer diagnosis and prognosis
|
|
BR112021025795A2
(pt)
|
2019-06-21 |
2022-02-01 |
H Lee Moffitt Cancer Center And Res Institute Inc A Florida Non Profit Corporation |
Terapia de combinação com bloqueio da semaforina-4d (sema4d) e terapia com dc1
|
|
CA3146433A1
(en)
|
2019-07-18 |
2021-01-21 |
Direct Biologics Llc |
Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use
|
|
BR112022008215A2
(pt)
|
2019-10-31 |
2022-07-12 |
Res Inst Nationwide Childrens Hospital |
Geração de células nk humanas primárias e expandidas knock-out de cd38
|
|
JP2023521837A
(ja)
|
2020-04-14 |
2023-05-25 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
大きな配列の汎コロナウイルスワクチン組成物
|
|
US11225508B1
(en)
|
2020-09-23 |
2022-01-18 |
The University Of North Carolina At Chapel Hill |
Mouse-adapted SARS-CoV-2 viruses and methods of use thereof
|
|
WO2022115474A1
(en)
|
2020-11-27 |
2022-06-02 |
General Nanotherapeutics Llc |
Methods and composition for treatment of immune-mediated diseases
|
|
US20230279442A1
(en)
|
2021-12-15 |
2023-09-07 |
Versitech Limited |
Engineered cas9-nucleases and method of use thereof
|
|
KR102436232B1
(ko)
*
|
2022-01-17 |
2022-08-25 |
주식회사 세명하이트 |
원통형 필터 제조방법 및 이에 따라 제조된 원통형 필터
|
|
US20250228940A1
(en)
|
2022-03-11 |
2025-07-17 |
Yale University |
Compositions and methods for efficient and stable genetic modification of eukaryotic cells
|
|
WO2023220644A1
(en)
|
2022-05-10 |
2023-11-16 |
Yale University |
Compositions and methods of synthetic ctla-4 tails for reprogramming of car-t cells and enhancement of anti-tumor efficacy
|
|
KR102751454B1
(ko)
*
|
2022-06-03 |
2025-01-10 |
현대제철 주식회사 |
전기로
|
|
KR102736561B1
(ko)
*
|
2022-06-03 |
2024-12-02 |
현대제철 주식회사 |
전기로
|
|
KR102777625B1
(ko)
*
|
2022-07-29 |
2025-03-11 |
현대제철 주식회사 |
전기로
|
|
KR102829902B1
(ko)
*
|
2022-07-29 |
2025-07-04 |
현대제철 주식회사 |
전기로
|
|
KR102793154B1
(ko)
*
|
2022-08-26 |
2025-04-07 |
현대제철 주식회사 |
전기로
|
|
KR102752443B1
(ko)
*
|
2022-08-26 |
2025-01-09 |
현대제철 주식회사 |
전기로
|
|
WO2024064824A2
(en)
|
2022-09-21 |
2024-03-28 |
Yale University |
Compositions and methods for identification of membrane targets for enhancement of nk cell therapy
|
|
WO2024102997A1
(en)
|
2022-11-11 |
2024-05-16 |
Peterson Jeff R |
Gout flare prevention methods using il-1β inhibitors
|
|
KR102799788B1
(ko)
*
|
2022-11-29 |
2025-04-22 |
현대제철 주식회사 |
전기로용 저취교반장치 및 이를 포함하는 전기로
|
|
WO2024155821A1
(en)
|
2023-01-18 |
2024-07-25 |
Yale University |
Chimeric antigen receptors (car) with intrinsically disordered regions and methods of use thereof
|
|
WO2024226829A2
(en)
|
2023-04-26 |
2024-10-31 |
Yale University |
Enpp3-binding molecules, compositions formed therefrom, and methods of use thereof for the treatment of cancer
|
|
WO2024238656A1
(en)
|
2023-05-15 |
2024-11-21 |
Yale Univeristy |
Chimeric antigen receptor compositions, car-mast cells formed therefrom, and methods of use thereof
|
|
US12269875B2
(en)
|
2023-08-03 |
2025-04-08 |
Jeff R. Peterson |
Gout flare prevention methods using IL-1BETA blockers
|
|
WO2025158400A1
(en)
|
2024-01-24 |
2025-07-31 |
Yale University |
Compositions and methods of natural killer cell hyperboosts for enhancement of nk cell therapy
|
|
US12502407B2
(en)
|
2024-04-25 |
2025-12-23 |
Direct Biologics, Llc |
Treatment of fistula with bone marrow mesenchymal stem cell derived extracellular vesicles
|
|
WO2025264861A1
(en)
|
2024-06-18 |
2025-12-26 |
Yale University |
Compositions of bi-functional alpha helical peptides and methods thereof for treating tdp-43 proteinopathies
|
|
WO2026006542A2
(en)
|
2024-06-26 |
2026-01-02 |
Yale University |
Compositions and methods for crispr/cas9 based reactivation of human angelman syndrome
|